|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||74.85 - 74.85|
|52-week range||74.85 - 74.85|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||26.41|
|Earnings date||27 Apr 2022 - 02 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Rates could spike sooner rather than later. Prepare your portfolio.
RAHWAY, N.J., May 20, 2022--Merck Receives Positive EU CHMP Opinion for KEYTRUDA as Adjuvant Treatment for Adult and Adolescent Patients With Stage IIB or IIC Melanoma
Yahoo Finance's Jared Blikre breaks down the stocks Warren Buffett's Berkshire Hathaway is buying and selling.